Karo
2009-04-07 22:04, Edited at: 2010-06-11 12:10Please note: Community posts are written by its members and not by Redeye’s research department. As a reader you’re always encouraged to critically analyze the content.
Saxat från Reuter/Yahoo Finance:
The results suggest eprotirome has the potential to open a new avenue for treating heart disease, according to a press statement released by the ACC. Eprotirome is designed to target thyroid hormones receptors in the liver that regulate cholesterol. (Recension från ACC)
Looking to the year ahead, Devani sees fewer major licensing transactions overall, although big deals are expected for key experimental drugs from companies such as NicOx (NCOX.PA), Karo Bio (KARO.ST), MediGene (MDGGn.DE), Alizyme (AZM.L), Transgene (TRNG.PA) and Neurosearch (NEUR.CO). (Artikel om vad som är på G i läkemedelsbranschen)
Det är inte bara vi som tycker KB har en bra produkt.